Autres langues GenKyoTex SA Euronext Paris

Actions

GKTX

FR0011790542

Cours en clôture Euronext Paris Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-.--%	-.--%

2022	Pixium Vision : la CDC passe sous les 10%	CF
2021	Calliditas Therapeutics acquiert les parts restantes de Genkyotex	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Calliditas Therapeutics : Acquires Remaining Stake in Genkyotex	07/10/21
Calliditas Therapeutics : announces acquisition of remaining Genkyotex minority shares	07/10/21
Genkyotex SA(ENXTPA:GKTX) dropped from CAC AllShares Index	05/10/21
Genkyotex SA(ENXTPA:GKTX) dropped from Next Biotech Index	05/10/21
Global markets live: Sanofi, ASML, Apple, United Airlines, Netflix...	29/09/21
Global markets live: Airbnb, Coinbase, Walt Disney,...	14/05/21
Genkyotex : provides business update and reports cash position at March 31, 2021	13/05/21
Calliditas Therapeutics : Year-End Report, 2020	19/02/21
Genkyotex Sa Reports Earnings Results for the Full Year Ended December 31, 2020	18/02/21
Calliditas Therapeutics : Year-End Report, 2020	18/02/21
Genkyotex : provides Q4 business update and reports cash position	27/01/21
Genkyotex : announces update for near term clinical development plan for setanaxib	25/01/21
Genkyotex : Chief Medical Officer Steps Down Amid Start of Phase 2/3 Study in Chronic Liver Disease	22/01/21
Genkyotex SA Announces Update for Near Term Clinical Development Plan for Setanaxib	22/01/21
Calliditas Therapeutics AB : - Positive Phase 1 results in high-dose setanaxib trial	19/01/21
Genkyotex : Reports Positive Results from Phase One Trial of Anti-fibrosis Drug Setanaxib	18/01/21
Calliditas Therapeutics : Positive Phase 1 results in high-dose setanaxib trial	18/01/21
Genkyotex Announces Positive Phase 1 Results Demonstrating Favorable Safety and Pharmacokinetic Profile of High-Dose Setanaxib	18/01/21
Calliditas Therapeutics : announces final outcome of simplified mandatory offer to the shareholders of Genkyotex	16/12/20
Calliditas Therapeutics AB (OM:CALTX) completed the acquisition of 37.3% stake in Genkyotex SA.	11/12/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GenKyoTex SA Euronext Paris

Actions

GKTX

FR0011790542

Autres langues

Filtres